We are live on ! Find out more
HCM

Hillman Capital Management Portfolio holdings

AUM $144M
1-Year Est. Return 7.02%
This Fund
S&P 500
This Quarter Est. Return
-5.11%
1 Year Est. Return
+7.02%
3 Year Est. Return
+20.27%
5 Year Est. Return
+21.27%
10 Year Est. Return
–
AUM
$283M
AUM Growth
-$27.9M
Cap. Flow
-$10.4M
Cap. Flow %
-3.67%
Top 10 Hldgs %
32.43%
Holding
54
New
2
Increased
9
Reduced
38
Closed
1

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$7.18M
2
ADBE icon
Adobe
ADBE
+$6.78M
3
EL icon
Estee Lauder
EL
+$2.92M
4
WBD icon
Warner Bros
WBD
+$2.06M
5
CVS icon
CVS Health
CVS
+$644K

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$10.9M
2
JWN
Nordstrom
JWN
+$2.14M
3
AMZN icon
Amazon
AMZN
+$1.77M
4
GSK icon
GSK
GSK
+$1.61M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.57M

Sector Composition

Rank Sector Weight
1 Healthcare 19.45%
2 Consumer Staples 15.24%
3 Communication Services 14.61%
4 Financials 12.23%
5 Technology 10.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.66T
$10.6M 3.74%
23,675
-2,083
-8% -$880K
AMZN icon
2
Amazon
AMZN
$2.9T
$9.59M 3.39%
49,642
-9,657
-16% -$1.77M
IFF icon
3
International Flavors & Fragrances
IFF
$21.4B
$9.58M 3.38%
100,579
-9,172
-8% -$841K
WFC icon
4
Wells Fargo
WFC
$269B
$9.57M 3.38%
161,123
-24,681
-13% -$1.46M
SPG icon
5
Simon Property Group
SPG
$71.1B
$9.35M 3.3%
61,594
-239
-0.4% -$35.2K
DD icon
6
DuPont de Nemours
DD
$19.6B
$9.07M 3.2%
89,783
-13,944
-13% -$1.37M
T icon
7
AT&T
T
$167B
$8.74M 3.09%
457,516
-53,878
-11% -$937K
WBD icon
8
Warner Bros
WBD
$69B
$8.62M 3.04%
1,158,862
+256,848
+28% +$2.06M
KMX icon
9
CarMax
KMX
$8.34B
$8.41M 2.97%
114,684
-295
-0.3% -$21.3K
BIIB icon
10
Biogen
BIIB
$30.8B
$8.33M 2.94%
35,954
+162
+0.5% +$35.2K
K
11
DELISTED
Kellanova
K
$8.28M 2.92%
143,491
-14,997
-9% -$885K
BA icon
12
Boeing
BA
$183B
$7.99M 2.82%
43,885
+202
+0.5% +$36K
ADBE icon
13
Adobe
ADBE
$102B
$7.78M 2.75%
+14,000
New +$6.78M
KHC icon
14
Kraft Heinz
KHC
$29B
$7.64M 2.7%
237,171
+1,497
+0.6% +$53.3K
BUD icon
15
AB InBev
BUD
$156B
$7.62M 2.69%
131,051
-12,622
-9% -$773K
GSK icon
16
GSK
GSK
$101B
$7.51M 2.65%
195,126
-38,360
-16% -$1.61M
BAX icon
17
Baxter International
BAX
$14.1B
$7.38M 2.61%
220,576
+1,614
+0.7% +$59.5K
CVS icon
18
CVS Health
CVS
$121B
$7.34M 2.59%
124,329
+10,291
+9% +$644K
EL icon
19
Estee Lauder
EL
$32B
$7.3M 2.58%
68,586
+22,297
+48% +$2.92M
INTC icon
20
Intel
INTC
$517B
$6.94M 2.45%
224,036
+19,345
+9% +$634K
BNY
21
Bank of New York Mellon
BNY
$111B
$6.72M 2.37%
112,230
-23,499
-17% -$1.36M
BMY icon
22
Bristol-Myers Squibb
BMY
$130B
$6.67M 2.35%
+160,529
New +$7.18M
CPB icon
23
Campbell Soup
CPB
$6.74B
$6.51M 2.3%
144,006
-797
-0.6% -$35.5K
GOOGL icon
24
Alphabet (Google) Class A
GOOGL
$4.2T
$6.5M 2.3%
35,700
-9,300
-21% -$1.57M
EMR icon
25
Emerson Electric
EMR
$91.8B
$6.48M 2.29%
58,831
-10,140
-15% -$1.12M
1
2 3

Similar funds

AL
Advaya LLP London, United Kingdom $144M AUM
KK
Karl Kapital San Francisco, California $144M AUM
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
I
Immersion Aventura, Florida $145M AUM 17.41% 1-Year Est. Return
AGM
Aragon Global Management Miami, Florida $143M AUM 65.8% 1-Year Est. Return
PU
Petiole USA New York $143M AUM 19.66% 1-Year Est. Return
TP
Teca Partners Austin, Texas $145M AUM 10.43% 1-Year Est. Return
12CM
11.2 Capital Management Las Vegas, Nevada $143M AUM

Hillman Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Hillman Capital Management held 54 positions worth $283M, down 9% from $311M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Hillman Capital Management withdrew a net $10.4M in Q2 2024, closing 1 position and reducing 38 holdings. Its most notable exit was TSMC, an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Consumer Staples and Communication Services.

Against the trend, Hillman Capital Management opened a new position in Bristol-Myers Squibb worth $6.67M.

  • Hillman Capital Management's largest Q2 2024 buy was Bristol-Myers Squibb: 160,529 shares worth $6.67M.
  • Hillman Capital Management added most to Estee Lauder in Q2 2024, an estimated $2.92M increase.
  • Hillman Capital Management's biggest Q2 2024 reduction was Nordstrom, cutting an estimated $2.14M.
  • Hillman Capital Management fully exited TSMC in Q2 2024, selling an estimated $10.9M.
  • Hillman Capital Management's ten largest holdings make up 32% of its $283M portfolio in Q2 2024.
  • Hillman Capital Management opened 2 new positions and closed 1 in Q2 2024.
  • Hillman Capital Management's portfolio value fell 9% quarter-over-quarter to $283M.

Based on Hillman Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.